A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C

Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection

(2015) Z. M. Younossi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Recent trends in preclinical drug-drug interaction studies of flavonoids - Review of case studies, issues and perspectives

(2015) Nuggehally R. Srinivas   PHYTOTHERAPY RESEARCH

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

(2014) Kris V. Kowdley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: The randomized PILLAR study

(2013) Michael W. Fried et al.   HEPATOLOGY

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

(2013) Kris V Kowdley et al.   LANCET

Novel Insights into the Pharmacology of Flavonoids

(2013) Barbara Romano et al.   PHYTOTHERAPY RESEARCH

Mitochondrial Dysfunction Leads to Deconjugation of Quercetin Glucuronides in Inflammatory Macrophages

(2013) Akari Ishisaka et al.   PLoS One

Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases

(2012) Shashi Bala et al.   HEPATOLOGY

Fluorescence Resonance Energy Transfer-Based Intracellular Assay for the Conformation of Hepatitis C Virus Drug Target NS5A

(2012) D. Bhattacharya et al.   JOURNAL OF VIROLOGY

Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics

(2011) Andrew Prussia et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity

(2011) L. Bachmetov et al.   JOURNAL OF VIRAL HEPATITIS

A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects

(2010) Serena A. Heinz et al.   BRITISH JOURNAL OF NUTRITION

Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial

(2010) Serena A. Heinz et al.   PHARMACOLOGICAL RESEARCH

Quercetin supplementation does not alter antioxidant status in humans

(2009) R. Andrew Shanely et al.   FREE RADICAL RESEARCH

The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production

(2009) Oscar Gonzalez et al.   HEPATOLOGY

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

(2009) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chronic quercetin ingestion and exercise-induced oxidative damage and inflammation

(2008) Steven R. McAnulty et al.   Applied Physiology Nutrition and Metabolism

Flavonoid Intake and Risk of Pancreatic Cancer in Male Smokers (Finland)

(2008) G. Bobe et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION